About FRONTIER BIO CORPORATION
Frontier Bio is a biotechnology company focused on developing engineered tissues and vascular grafts to address the global organ transplant shortage and reduce reliance on animal testing. Their technology involves creating bioresorbable scaffolds seeded with patient stem cells to form living vascular grafts.
Development of tissue-engineered blood vessels for cardiovascular disease and traumaCreation of bioresorbable vascular grafts seeded with patient stem cellsCommercialization of human-based tissue models for preclinical testingBioprinting and advanced tissue engineering services
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to FRONTIER BIO CORPORATION right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.